Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Performance Update

22 Sep 2015 07:00

RNS Number : 7318Z
BlueCrest AllBlue Fund Ltd
22 September 2015
 



FOR IMMEDIATE RELEASE

 

22 September 2015

 

BLUECREST ALLBLUE FUND LIMITED

FACTSHEET - AUGUST 2015

 

"Creditable performance in extremely challenging conditions"

 

BlueCrest AllBlue Fund Limited (BCAB) fell slightly in August, by 0.1%, a creditable performance given extremely challenging conditions. This brings the year to date return to 2.6% (Sterling Class NAV) and the rolling 12 month return to 3.7%. Risk measures were stable with volatility of 3.1% being around historical averages.

 

Equity markets were particularly volatile in August, led by the slump in Chinese stocks. Global equities finished the month down around 7%. Other asset classes such as bonds and commodities were also impacted and there was notable currency volatility, again triggered by China as the RMB was devalued.

 

"Growing opportunities in developed fixed income"

 

Five of the seven underlying strategies generated positive performance, with only BlueCrest Multi Strategy Credit and BlueCrest Quantitative Equity detracting.

 

BlueCrest Capital International once again produced solid gains across all regions. Directional trading strategies were the main driver of returns for August with profits locked in as markets gyrated. Long positioning in Sterling and Dollar rates was fruitful with mortgages and relative value trading providing good tactical trading opportunities. Despite market conditions, volatility trading was flat for the month as longer term implied volatility remained stable. The AllBlue Allocation Committee decided to further increase the allocation to BlueCrest Capital International by 3% for September to 22%, the largest allocation in AllBlue, given the growing opportunities in developed market fixed income.

 

BlueCrest Multi Strategy Credit lost just 0.1% on the month against a backdrop of weak credit markets, volatility and lower liquidity. Gains came primarily from trading volatility and short positions in ABS. Illiquidity particularly impacted the European high yield market where a number of positions were hit by broader market falls notwithstanding near term idiosyncratic catalysts that are expected to realise value.

 

Despite the extreme conditions in equity markets, BlueCrest Equity Strategies was the strongest performing fund for the month, gaining 0.7%. All three strategies performed well, with Long/Short benefiting from stock selection decisions in financials and in generalist portfolios. Relative Value and Event Driven strategies performed strongest in Europe where tactical hedging around high conviction positions was successful. BlueCrest Quantitative Equity had a more difficult month with mixed outcomes across regions and signal sets. The Allocation Committee reduced the allocation to BlueCrest Quantitative Equity by 3% for September to 20%.

 

"The Company was active in buying back"

 

The Company was active in buying back shares during August as one or two more persistent sellers pushed the discount out beyond 5%.

Disclaimer:

This document is directed only at: (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005; or (ii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and persons who receive this document who do not fall within (i) or (ii) above should not rely on or act upon this document.

 

This document is issued by BlueCrest AllBlue Fund Limited (the "Company") to and for the information of its existing shareholders and does not in any jurisdiction constitute investment advice or an invitation to invest in the shares or any other securities of the Company or any other entity (body corporate or otherwise).

 

The Company has used reasonable care to ensure that the information included in this document is accurate at the date of its issue, but does not undertake to update or revise the information, including any information relating to AllBlue Limited and its underlying funds (the "Funds") provided by BlueCrest Capital Management (UK) LLP or any member of the BlueCrest group of companies (as applicable) ("BlueCrest"), or guarantee the accuracy of such information. To the extent permitted by law neither the Company, the Funds, BlueCrest nor their directors or officers shall be liable for any loss or damage that anyone may suffer in reliance on such information.

 

The information in this document may be changed by the Company at any time. Past performance cannot be relied on as a guide to future performance. The Company's investment strategy is speculative and entails substantial risks. The value of an investment may go down as well as up and some or all of the total amount invested may be lost. This document may not, in whole or in part, directly or indirectly, be taken, transmitted or distributed into the United States of America, its territories or possessions or made available to any national, resident or citizen of the United States of America or any other jurisdiction where applicable laws prohibit its release, distribution or publication. Any failure to comply with these restrictions may be a violation of the law in relevant jurisdictions.

 

JTC (Guernsey) Limited

Secretary

 

Tel: Guernsey 01481 702400

 

END OF ANNOUNCEMENT

E&OE - in transmission

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRDMGZLVMZGKZM
Date   Source Headline
29th Jul 20204:32 pmRNSNet Asset Value - Weekly Estimate
29th Jul 20202:17 pmRNS2019 Redemption Portfolio
29th Jul 20202:15 pmRNSNet Asset Value - Month End Final
21st Jul 20204:22 pmRNSNet Asset Value - Weekly Estimate
16th Jul 20202:44 pmRNSNet Asset Value - Weekly Estimate
8th Jul 20201:13 pmRNSNet Asset Value - Weekly Estimate
2nd Jul 20205:11 pmRNSProvision 4 of the UK Corporate Governance Code
2nd Jul 202010:03 amRNSNet Asset Value(s) - Weekly Estimate
26th Jun 20203:11 pmRNSHolding(s) in Company
24th Jun 20205:07 pmRNSNet Asset Value - Weekly Estimate
23rd Jun 20205:16 pmRNS2019 Redemption Portfolio
23rd Jun 20205:15 pmRNSNet Asset Value(s) - Month End Final
17th Jun 202012:46 pmRNSNet Asset Value(s) - Weekly Estimate
12th Jun 202011:27 amRNSNet Asset Value(s) - Weekly Estimate
4th Jun 20202:39 pmRNSNet Asset Value(s) - Weekly Estimate
28th May 20204:17 pmRNSNet Asset Value(s) - Month End Final
28th May 20204:08 pmRNS2019 Redemption Portfolio
28th May 20203:46 pmRNSNet Asset Value(s) - Weekly Estimate
21st May 20205:01 pmRNSNet Asset Value(s) - Weekly Estimate
15th May 20203:42 pmRNSNet Asset Value(s) - Weekly Estimate
6th May 20204:06 pmRNSNet Asset Value(s) - Weekly Estimate
5th May 20201:58 pmRNSDisclosure of rights attached to equity shares
5th May 20201:47 pmRNSDirector/PDMR Shareholding
4th May 20205:16 pmRNS2019 Redemption Portfolio
4th May 20204:41 pmRNSNet Asset Value(s) - Month End Final
1st May 202010:11 amRNSCorrection to Disclosure of Notifiable Interests
30th Apr 20203:39 pmRNSNet Asset Value(s) - Weekly Estimate
28th Apr 20206:31 pmRNSDirector/PDMR Shareholding
27th Apr 20207:00 amRNSNotice of AGM
27th Apr 20207:00 amRNSAnnual Financial Report
23rd Apr 20204:53 pmRNSNet Asset Value(s) - Weekly Estimate
17th Apr 20203:39 pmRNSNet Asset Value(s) - Weekly Estimate
17th Apr 20209:15 amRNSNet Asset Value(s) - Weekly Estimate
14th Apr 20205:12 pmRNSCash Exit Payment
9th Apr 20205:39 pmRNSNet Asset Value(s) - Monthly Estimate
2nd Apr 20202:53 pmRNS2019 Redemption Portfolio
2nd Apr 20202:41 pmRNSNet Asset Value(s) - Weekly Estimate
26th Mar 20205:05 pmRNSNet Asset Value(s) - Month End Final
26th Mar 20204:53 pmRNSNet Asset Value(s) - Weekly Estimate
19th Mar 20201:31 pmRNSNet Asset Value(s)- Weekly Estimate
13th Mar 202011:41 amRNSHolding(s) in Company
12th Mar 20209:46 amRNSNet Asset Value(s) - Weekly Estimate
9th Mar 202012:20 pmRNSNet Asset Value(s) - Weekly Estimate
3rd Mar 20205:02 pmRNS2019 Redemption Portfolio
2nd Mar 20205:29 pmRNSNet Asset Value(s) - Month End Final
26th Feb 20203:33 pmRNSNet Asset Value(s) - Weekly Estimate
20th Feb 20202:05 pmRNSResult of EGM
19th Feb 20203:50 pmRNSNet Asset Value(s) - Weekly Estimate
12th Feb 20205:13 pmRNSNet Asset Value(s) - Weekly Estimate
7th Feb 20209:17 amRNS2019 Redemption Portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.